No Non-Monetary Consideration for Sales. Without the prior written consent of PROGENICS, BMS and its Affiliates and Sub-sublicensees shall not accept or solicit any non-monetary consideration in the sale of Licensed Products other than as would be reflected in Net Sales. The use by BMS and its Affiliates and Sub-sublicensees of commercially reasonable amounts of Licensed Products for clinical trials and promotional sampling shall not violate this provision.
Appears in 2 contracts
Samples: Joint Development and Master License Agreement (Progenics Pharmaceuticals Inc), Joint Development and Master License Agreement (Progenics Pharmaceuticals Inc)
No Non-Monetary Consideration for Sales. Without the prior written consent of PROGENICS, BMS and its Affiliates and Sub-sublicensees shall not accept or solicit any non-monetary consideration in the sale of Aquila Licensed Products other than as would be reflected in Net Sales. The use by BMS and its Affiliates and Sub-sublicensees of commercially reasonable amounts of Aquila Licensed Products for clinical trials and promotional sampling shall not violate this provision.
Appears in 1 contract
Samples: Sublicense Agreement (Progenics Pharmaceuticals Inc)
No Non-Monetary Consideration for Sales. Without the prior written consent of PROGENICS, BMS and its Affiliates and Sub-sublicensees shall not accept or solicit any non-monetary consideration in the sale of Licensed S-K Products other than as would be reflected in Net Sales. The use by BMS and its Affiliates and Sub-sublicensees of commercially reasonable amounts of Licensed S-K Products for clinical trials and promotional sampling shall not violate this provision.
Appears in 1 contract
Samples: Sublicense Agreement (Progenics Pharmaceuticals Inc)
No Non-Monetary Consideration for Sales. Without the prior written consent of PROGENICS, BMS and its Affiliates and Sub-sublicensees shall not accept or solicit any non-monetary consideration in the sale of Licensed Regents' Products other than as would be reflected in Net Sales. The use by BMS and its Affiliates and Sub-sublicensees of commercially reasonable amounts of Licensed Regents' Products for clinical trials and promotional sampling shall not violate this provision.
Appears in 1 contract
Samples: Sublicense Agreement (Progenics Pharmaceuticals Inc)